This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Bausch & Lomb moves to dismiss US antitrust claims over eye supplements

( March 30, 2022, 22:31 GMT | Official Statement) -- MLex Summary: Bausch & Lomb and PF Consumer Healthcare moved to dismiss claims that they attempted to monopolize the eye health supplement market to keep competing products off the market, arguing that Pharmavite and its affiliates are only trying to avoid a patent infringement suit. Additionally, PF said that it does not have any presence whatsoever in the market.See documents below. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections